secwatch.observer — SEC 8-K summary
======================================

Issuer:     TANDEM DIABETES CARE INC (TNDM)
CIK:        0001438133
Form:       8-K
Filed at:   2023-05-03T23:59:59+00:00
Accession:  0001438133-23-000066
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tandem Diabetes Q1 revenue $186M, up 14% YoY; net loss $(49.1M)
---------------------------------------------------------------

- Revenue $186.0M (+14% YoY); GAAP net loss $(49.1M) or $(0.75) per share.
- Non-GAAP adjusted EBITDA loss $(7.3M) vs $(11.7M) loss a year ago.
- Total pump shipments 37,923, up 5% YoY; U.S. sales $148.7M (+19% YoY).
- International revenue $37.3M, flat YoY; currency headwinds of $4.0M.
- FY 2023 revenue guidance reaffirmed: $790M-$810M; expects gross margin 49-50%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1438133/000143813323000066/0001438133-23-000066-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1438133/000143813323000066/tndm-20230503.htm
  HTML page:      https://secwatch.observer/filing/0001438133-23-000066

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer